Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: AcuCort AB

Market Cap 153M 16.32M 14.05M 12.95M 12.14M 22.78M 1.55B 23.02M 59.57M 755M 61.26M 59.95M 2.63B P/E Ratio 2024
-3.61x
P/E Ratio 2025 -5x
Enterprise Value 126M 13.45M 11.57M 10.67M 10M 18.76M 1.28B 18.97M 49.07M 622M 50.46M 49.39M 2.16B EV / Sales 2024
11.3x
EV / Sales 2025 17x
Free-Float
36.58%
Yield 2024 *
-
Yield 2025 -
1 day+1.55%
1 week-3.82%
Current month-5.22%
1 month-6.30%
3 months+11.60%
6 months+11.60%
Current year+9.00%
1 week 0.62
Extreme 0.624
0.7
1 month 0.62
Extreme 0.624
0.74
Current year 0.5
Extreme 0.499
0.95
1 year 0.5
Extreme 0.499
0.95
3 years 0.33
Extreme 0.327
1.45
5 years 0.33
Extreme 0.327
5.42
10 years 0.33
Extreme 0.327
9.5
Manager TitleAgeSince
Chief Executive Officer 55 09/08/2020
Corporate Officer/Principal 53 14/10/2025
Director TitleAgeSince
Director/Board Member 68 08/02/2017
Chairman 63 01/01/2018
Director/Board Member 79 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.55%-3.82%-9.17%-52.26% 16.32M
-0.37%-0.37%-7.22%-25.96% 15.39B
+2.93%-2.23%-23.70%-28.51% 7.24B
-1.02%+1.79%-17.28%-12.38% 5.73B
+4.47%+9.30%-13.07%-28.75% 3.9B
+0.30%+0.16%-35.08%-10.39% 3.38B
+1.38%-0.98%-24.68%-45.43% 3.26B
+4.44%+7.85%+5.59%-37.91% 2.89B
+0.02%+6.45%+118.84% - 2.73B
-0.02%-0.87%-22.52%-5.98% 2.59B
Average +1.37%+1.52%-2.83%-27.51% 4.71B
Weighted average by Cap. +0.96%+0.86%-7.42%-24.74%

Financials

2024 2025
Net sales 7.72M 822K 707K 652K 611K 1.15M 78.13M 1.16M 3M 37.99M 3.08M 3.02M 132M 6.68M 711K 612K 565K 529K 993K 67.66M 1M 2.6M 32.9M 2.67M 2.61M 114M
Net income -17.4M -1.85M -1.59M -1.47M -1.38M -2.58M -176M -2.61M -6.76M -85.64M -6.95M -6.8M -298M -26.19M -2.79M -2.4M -2.21M -2.07M -3.89M -265M -3.93M -10.17M -129M -10.46M -10.24M -449M
Net Debt -2.77M -295K -254K -234K -219K -412K -28.07M -416K -1.08M -13.65M -1.11M -1.08M -47.49M -27.01M -2.88M -2.47M -2.28M -2.14M -4.01M -273M -4.06M -10.49M -133M -10.79M -10.56M -463M
Logo AcuCort AB
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Employees
5
Date Price Change Volume
12/06/26 0.6540 kr +1.55% 321,333
11/06/26 0.6440 kr -1.53% 158,702
10/06/26 0.6540 kr -0.61% 180,673
09/06/26 0.6580 kr 0.00% 182,090
08/06/26 0.6580 kr -3.24% 183,512
  1. Stock Market
  2. Stocks
  3. ACUC Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!